What are the highlighted features of the 2020 edition of the VA/DoD Dyslipidemia CPG?
The 2020 edition of the VA/DoD Dyslipidemia CPG provides practice recommendations for the management of dyslipidemia and adheres to the National Academy of Medicine's (NAM) eight principles of trustworthy guidelines, including the management of COI, interdisciplinary stakeholder involvement, and representation from the broad spectrum of providers engaged in the treatment and management of dyslipidemia. The CPG also uses GRADE methodology, which takes into account factors beyond the strength of the evidence, including balancing desired outcomes with potential harms of the intervention, equity of resource availability, the potential for variation in patient values and preferences, and other considerations (e.g., resource use, subgroup considerations) as appropriate. Additionally, the CPG includes the newest U.S. Food and Drug Administration (FDA) approved dyslipidemia treatments and offers a one page algorithm to assist with training providers and facilitate the translation of guideline recommendations into effective practice.